Indegene Implements MFT Gateway for Major European Pharma | MFTGateway
Indegene required an AS2 gateway to be deployed to facilitate communications with a large pharmaceutical corporation in Europe.
Background
Indegene Inc. is a technology-led healthcare solutions provider. It combines deep industry expertise with fit-for-purpose technology in an agile and scalable operating model, and offers research and development, and management services to healthcare and pharmaceutical enterprises. Many of the leading global healthcare organizations rely on its technology to deliver effective and efficient clinical, medical, and commercial outcomes every day. From strategy to execution, Indegene Inc. enables healthcare organizations to be future ready. It was founded in 1998 and is based in Bangalore, India. Indegene has offices in North America, Europe, China and India.
Solution
Based on the successful deployment by Indegene a few months earlier, the MFT Gateway solution by Aayu Technologies LLC, was known to be the best suited platform. However to meet the european regulations and laws, the deployment had to be performed in the EU region of the AWS cloud.
The MFT Gateway solution has provided us with a secure, scalable, reliable, and easily
manageable EDI platform.
The ability to integrate the solution into our services using native AWS technologies has
allowed us to get our services to enterprise customers rapidly and more cost effectively.
Anand Tiwari
Senior Director Technology
Development
Similar to its previous deployment, Indegene requested Aayu
Technologies to deploy the MFT Gateway solution into an isolated AWS account under its control,
and within the European region. This allowed Indegene to be in full control and ownership of all
data being exchanged and stored, to meet the regulatory requirements.
The deployment also allowed customizations required by Indegene, specifically to use on-rest
encryption of files on S3 storage, and use of a dedicated Virtual Private Cloud (VPC) for
outbound messages,
utilizing a static IP. The use of 2 way SSL with client authentication was another requirement
to be fulfilled when connecting to the pharmaceutical customer, and the MFT gateway met all
requirements.
The customizations also included a Simple Queue Service (SQS) notification to notify Indegene
systems of events, which the target systems then used to fetch message payloads from S3. Using
the S3 integration capabilities,
the Indegene systems could both send and receive messages over AS2 by simply copying to, and
reading from the allocated S3 storage bucket.
The system was moved into production from July 2021 and is successfully processing messages,
while being under the full control and ownership of Indegene.
